Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Brachytherapy; Survival;
مقالات ISI درمان محرومیت از آندروژن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; gonadotropin-releasing hormone; physician's practice patterns; neoplasm recurrence; local; neoplasm metastasis; ADT; androgen deprivation therapy; CADT; continuous androgen deprivation therapy; GnRH; gonadotropin-releasing hormone; IA
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; biological markers; risk assessment; molecular diagnostic techniques; ADT; androgen deprivation therapy; AS; active surveillance; Columbia; New York-Presbyterian Hospital, Columbia University; DVU; Delaware Valley Urology, LLC; EBRT;
Keywords: درمان محرومیت از آندروژن; Metastatic prostate cancer; Overall survival; Prostate cancer; Androgen deprivation therapy; Site of metastases; Number of metastases;
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Comorbidity; Other-cause mortality; Competing-risks
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Cardiovascular; Prostate cancer
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Prostate cancer
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Radiotherapy; Androgen deprivation therapy; Brachytherapy.
Keywords: درمان محرومیت از آندروژن; AA; abiraterone acetate; ADT; androgen deprivation therapy; AR; androgen receptor; AR-V; AR splice variant; CRPC; castration-resistant prostate cancer; CTC; circulating tumor cell; CYP; cytochrome P450; FDA; Food and Drug Administration; LBD; ligand-bindi
Keywords: درمان محرومیت از آندروژن; Activities of daily living; Exercise; Men; Muscle strength; Neoplasm; Rehabilitation; Strength training; ADT; androgen deprivation therapy; FLEX; placebo control program of seated stretching exercise; ITT; intention-to-treat; LLFDI; Late-Life Function and
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; castration-resistant; ADT; androgen deprivation therapy; AUA; American Urological Association; CRPC; castration resistant prostate cancer; FDA; Food and Drug Administration; mCRPC; metastatic castration resistant prostate cancer; PSA;
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; quality of health care; SEER program; Medicare; ADT; androgen deprivation therapy; SEER; Surveillance, Epidemiology and End Results;
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; registries; epidemiologic research design; observational study as topic; data collection; ADT; androgen deprivation therapy; AQUA; AUA Quality Registry; AUA; American Urological Association; CAPRA; Cancer of the Prostate Risk Assessme
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Quality of life; Diastolic blood pressure; Fatigue; Exercise; Diet
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Prostate cancer; Side effects; Renal failure; Competing risks; Acute kidney injury;
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Biliary disease; GnRH agonist; Prostate cancer; Orchiectomy;
Keywords: درمان محرومیت از آندروژن; epithelial plasticity; epithelial–mesenchymal transition; mesenchymal–epithelial transition; androgen receptor; androgen deprivation therapy; chemotherapy
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Radiation therapy; Risk score; Fractures
Keywords: درمان محرومیت از آندروژن; ADT; androgen deprivation therapy; BALP; bone alkaline phosphatase; BMPs; bone morphogenetic proteins; BPs; bisphosphonates; CRPC; castration-resistant prostate cancer; ECM; extracellular matrix; ET-1; endothelin-1; ETAR; endothelin A receptor; ETBR; endo
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; GnRH antagonist; Prostate cancer;
Keywords: درمان محرومیت از آندروژن; AD; Alzheimer's dementia; AN; anastrazole; ADT; androgen deprivation therapy; APOE É4; apolipoprotein E É4 allele; BDI; Beck depression inventory; CES-D; Center for Epidemiologic Studies Depression; DHT; dihydrotestosterone; E2; Estradiol; GDS; Geriatri
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Androgen metabolism; Serum testosterone;
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Bone turnover; Prostate cancer; Skeletal-related events;
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; locally advanced prostate cancer; Prostatectomy; prostate cancer; radiotherapy; Survival;
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Prostate cancer; Comorbidity; Diabetes; Cardiac death;
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; external beam radiotherapy; high dose rate brachytherapy; prostate cancer; quality of life; sexual function;
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Prostate cancer; Libido; Estrogen; Male sexual function; Castrated animals; Orgasm; Skin sensitivity;
The Relationship between Hot Flashes and Testosterone Recovery after 12 Months of Androgen Suppression for Men with Localised Prostate Cancer in the ASCENDE-RT Trial
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; brachytherapy; external beam radiotherapy; hot flashes; prostate cancer; testosterone recovery;
Prognostic correlation of cell cycle progression score and Ki-67 as a predictor of aggressiveness, biochemical failure, and mortality in men with high-risk prostate cancer treated with external beam radiation therapy
Keywords: درمان محرومیت از آندروژن; pts; patients; IHC; immunohistochemical; HE; hematoxylin and eosin; CCP; cell cycle progression; ADT; androgen deprivation therapy; FFbF; freedom from biochemical failure; OS; overall survival; GU; genitourinary; GI; gastrointestinal; CTCv3.0; common term
ReviewC-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer
Keywords: درمان محرومیت از آندروژن; aa; amino-acids; ADT; androgen deprivation therapy; AR; androgen receptor; ARÎLBD; androgen receptor lacking a functional ligand binding domain; AR-V; AR splice variant; BET; bromodomain and extra-terminal; CE; cryptic exon; CRPC; castration-resistant pr
Original ArticleInhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Castration; Bone metastasis; Osteoclast; Osteoprotegerin; Receptor activator of nuclear factor kappa-B ligand; ADT; androgen deprivation therapy; ANOVA; analysis of variance; AR; androgen receptor; BMAs; bone-modifying agents; BMD; bone m
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; neoplasm recurrence; local; positron-emission tomography; fluciclovine F-18; tomography; emission-computed; ADT; androgen deprivation therapy; BCR; biochemical recurrence; BED-001; Retrospective Observational Study Investigating Fluci
Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Brachytherapy; High dose rate; Androgen deprivation therapy; Whole pelvic irradiation;
An androgen-regulated miR-2909 modulates TGFβ signalling through AR/miR-2909 axis in prostate cancer
Keywords: درمان محرومیت از آندروژن; TGFβ receptor II; TGFBR2; Prostate cancer; PCa; Androgen deprivation therapy; ADT; Hormone-sensitive PCa; HSPC; Apoptosis antagonizing transcription factor; AATF; Androgen receptor; AR; Dihydrotestosterone; DHT; PSA; Prostate Specific Antigen; Estrogen r
Original ResearchAndrogen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance data
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Ischaemic events; Cardiovascular morbidity; Cardiovascular risk; AA; antiandrogen; ADT; androgen deprivation therapy; ATC; anatomical, therapeutics, and chemical classification; CAB; combined androgen blockad
Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
Keywords: درمان محرومیت از آندروژن; Prostatic adenocarcinoma; Androgen deprivation therapy; Castration; Radiation therapy; Somatic alterations; Active surveillance; Indolent; Personalized medicine; Actionable target;
HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions
Keywords: درمان محرومیت از آندروژن; Androgen receptor; HOXB13; HOXB13(G84E); MEIS1; MEIS2; PBX; Prostate; TALE; ADT; Androgen Deprivation Therapy; AR; Androgen Receptor; HOX; Homeobox; MEIS; Murine Ectopic Integration Site; PIN; Prostatic Intraepithelial Neoplasia; PSA; Prostate-Specific An
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: AÂ systematic review and meta-analysis
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Metastases; Abiraterone; Systematic review; Meta-analysis; Androgen deprivation therapy;
Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A2 receptor: Implications for thromboxane- and androgen- dependent neoplastic and epigenetic responses in prostate cancer
Keywords: درمان محرومیت از آندروژن; ADT; androgen deprivation therapy; AR; androgen receptor; ARE; androgen response element; AA; arachidonic acid; BCR; biochemical recurrence; ChIP; chromatin immunoprecipitation; COX; cyclooxygenase/prostaglandin G2/H2 synathase; CRPC; castrate resistant p
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT
Keywords: درمان محرومیت از آندروژن; ADT-free survival; Androgen deprivation therapy; Oligometastatic recurrence of prostate cancer; PSA response; SBRT;
Variant Histology and Clinicopathological Features of Prostate Cancer in Men Younger than 50 Years Treated with Radical Prostatectomy
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; neoplasms; cystic; mucinous; and serous; age of onset; prostatectomy; phenotype; ADT; androgen deprivation therapy; BCR; biochemical recurrence; GS; Gleason score; IDC; intraductal carcinoma; IHC; immunohistochemistry; ISUP; Internati
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
Keywords: درمان محرومیت از آندروژن; bladder neoplasms; neoplasm recurrence; local; androgen antagonists; prevention and control; 5-alpha reductase inhibitors; ADT; androgen deprivation therapy; AR; androgen receptor; AST; androgen suppression therapy; BCG; bacillus Calmette-Guérin; BPH; be
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; prostatectomy; risk; treatment outcome; ADT; androgen deprivation therapy; BCR; biochemical recurrence; BFS; biochemical recurrence-free survival; EBRT; external beam radiation therapy; EF; erectile function; HR; high risk; IIEF-5; In
Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; salvage therapy; radiotherapy; prostatectomy; prostate-specific antigen; ADT; androgen deprivation therapy; ART; adjuvant radiotherapy; bRFS; biochemical relapse-free survival; DMFS; distant metastasis-free survival; FF-SADT; freedom
Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer
Keywords: درمان محرومیت از آندروژن; 5-aza-dC; 5-aza-2â²-deoxycytidine; AA; arachidonic acid; ADT; androgen deprivation therapy; AR; androgen receptor; BCR; biochemical recurrence; ChIP; chromatin immunoprecipitation; CNA; copy number alteration; COX; cyclooxygenase/prostaglandin G2/H2 synt
Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells
Keywords: درمان محرومیت از آندروژن; Antiandrogen; Prostate cancer; Statin; ADT; androgen deprivation therapy; AR; androgen receptor; DHT; dihydrotestosterone; DMSO; dimethyl sulfoxide; FCS; fetal calf serum; LC3B; microtubule-associated protein 1 light chain 3B; LC3-II; autophagosome-associ
Should We Try Antiandrogen Withdrawal in Castration-Resistant Prostate Cancer Patients? Insights From a Retrospective Study
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Antiandrogen withdrawal syndrome; Hormone therapy; Nonsteroidal antiandrogens; Prostate-specific antigen;
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Docetaxel; Metastatic noncastrate prostate cancer; Metastatic volume;
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Hormone therapy; Radiation therapy; Cardiovascular mortality; Androgen deprivation therapy; Survival;
Original Article - Prostate CancerEstimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Clinical practice; External beam radiotherapy; Impact; Knowledge translation; Prostate cancer;